You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 48 No. 12, December 1991 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL CONTRIBUTIONS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (17)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neurologic Complications of Nonneuronopathic Gaucher's Disease

R. P. Grewal, MD; S. H. Doppelt, MD; M. A. Thompson, MD, PhD; D. Katz, MD; R. O. Brady, MD; N. W. Barton, MD, PhD

Arch Neurol. 1991;48(12):1271-1272.


Abstract

• We describe eight patients with type 1 Gaucher's disease who developed neurologic complications that were secondary to systemic features of the illness. Four patients experienced neurologic difficulties because of coagulopathy, and the other four patients had involvement of the nervous system secondary to skeletal disease. Early recognition of these complications in patients with type 1 Gaucher's disease may lead to improved neurologic outcome.



Author Affiliations

From the Developmental and Metabolic Neurology Branch (Drs Grewal, Brady, and Barton) and Office of the Clinical Director (Dr Katz), National Institute of Neurological Disorders and Stroke (NINDS), and Laboratory of Pathology, National Cancer Institute (Dr Thompson), National Institutes of Health, Bethesda, Md; and Department of Orthopedic Surgery, Massachusetts General Hospital, Boston (Dr Doppelt).


Footnotes

Accepted for publication July 2, 1991.

Reprint requests to National Institute of Neurological Disorders and Stroke, Bldg 10, Room 3DO3, National Institutes of Health, Bethesda, MD 20892 (Dr Grewal).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Gaucher's disease with Parkinson's disease: Clinical and pathological aspects
Bembi et al.
Neurology 2003;61:99-101.
ABSTRACT | FULL TEXT  

Gaucher Disease: Recommendations on Diagnosis, Evaluation, and Monitoring
Charrow et al.
Arch Intern Med 1998;158:1754-1760.
ABSTRACT | FULL TEXT  

The Role of Neurogenetics in Gaucher Disease
Brady et al.
Arch Neurol 1993;50:1212-1224.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1991 American Medical Association. All Rights Reserved.